Annovis Bio Inc (ANVS)

Finanzdaten der Annovis Bio Inc-Aktie (ANVS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
	20.18%14.38	18.01	9.71	7.43	6.27
Research and Development	28.19%12.01	16.72	8.75	6.29	5.16
Operating Income/Loss	20.18%-14.38	-18.01	-9.71	-7.43	-6.27
Nonoperating Income/Loss	209.19%-0.44	0.41	-0.13	0.17	0.05
Income Tax Expense/Benefit	-	-	-	-	-
	15.82%-14.82	-17.61	-9.83	-7.26	-6.22
Attributable To Parent	15.82%-14.82	-17.61	-9.83	-7.26	-6.22
Basic Average Shares	34.73%37.52	27.85	-	19.69	19.49
Diluted Average Shares	34.73%37.52	27.85	-	19.69	19.49
Basic Earnings Per Share	36.51%-0.40	-0.63	-	-0.37	-0.32
Diluted Earnings Per Share	36.51%-0.40	-0.63	-	-0.37	-0.32